Cargando…
Glucagon and other proglucagon-derived peptides in the pathogenesis of obesity
Because of differential processing of the hormone precursor, proglucagon, numerous peptide products are released from the pancreatic alpha cells and the intestinal L-cells in which the (pro)glucagon gene is expressed. Of particular interest in relation to obesity are glucagon from the pancreas and o...
Autor principal: | Holst, Jens Juul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386348/ https://www.ncbi.nlm.nih.gov/pubmed/35990325 http://dx.doi.org/10.3389/fnut.2022.964406 |
Ejemplares similares
-
Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2
por: Mulvihill, Erin E.
Publicado: (2018) -
Editorial: Proglucagon-Derived Peptides
por: Flatt, Peter R., et al.
Publicado: (2021) -
Proglucagon-Derived Peptides as Therapeutics
por: Lafferty, Ryan A., et al.
Publicado: (2021) -
Variation in the Evolution and Sequences of Proglucagon and the Receptors for Proglucagon-Derived Peptides in Mammals
por: Irwin, David M.
Publicado: (2021) -
Heterogeneity of glucagonomas due to differential processing of proglucagon-derived peptides
por: Challis, Benjamin G, et al.
Publicado: (2015)